Medical therapy of specific clinical presentations

Details

Serval ID
serval:BIB_BBFCC2488CC0
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Medical therapy of specific clinical presentations
Journal
Gastroenterology Clinics of North America
Author(s)
Michetti  P., Peppercorn  M. A.
ISSN
0889-8553 (Print)
Publication state
Published
Issued date
06/1999
Volume
28
Number
2
Pages
353-70, viii
Notes
Journal Article
Review --- Old month value: Jun
Abstract
A pluridisciplinary approach that integrates medical therapy with surgery and other aspects of patient care, such as nutritional and psychosocial support, is essential to the management of patients with inflammatory bowel disease (IBD). Despite new medical therapies, such as 5-amino-salicylic acid compounds, steroids, and immunomodulators, the treatment of patients with IBD remains challenging. Success depends on the appropriate use of the available medications in relation to the severity and localization of the disease. The introduction of novel immunomodulating agents such as antitumor necrosis factor alpha is likely to have a major influence on the current therapeutic strategies. This article describes the use of the available medications in the most common clinical presentations of IBD.
Keywords
Adrenal Cortex Hormones/therapeutic use Anti-Inflammatory Agents/therapeutic use Colitis, Ulcerative/drug therapy Crohn Disease/drug therapy Drug Resistance Humans Inflammatory Bowel Diseases/*drug therapy Recurrence Severity of Illness Index Steroids
Pubmed
Web of science
Create date
25/01/2008 16:01
Last modification date
20/08/2019 15:30
Usage data